A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, called Apt1,…
Continue Reading
News Source: medicalxpress.com
Leave a Reply